Cargando…

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome

Patient-specific induced pluripotent stem cells (iPSCs) will assist research on genetic cardiac maladies if the disease phenotype is recapitulated in vitro. However, genetic background variations may confound disease traits, especially for disorders with incomplete penetrance, such as long-QT syndro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellin, Milena, Casini, Simona, Davis, Richard P, D'Aniello, Cristina, Haas, Jessica, Ward-van Oostwaard, Dorien, Tertoolen, Leon G J, Jung, Christian B, Elliott, David A, Welling, Andrea, Laugwitz, Karl-Ludwig, Moretti, Alessandra, Mummery, Christine L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Molecular Biology Organization 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981141/ https://www.ncbi.nlm.nih.gov/pubmed/24213244 http://dx.doi.org/10.1038/emboj.2013.240

Ejemplares similares

A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
por: Sala, Luca, et al.
Publicado: (2016)

Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)
por: Sala, Luca, et al.
Publicado: (2017)

Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias
por: Brandão, Karina O., et al.
Publicado: (2020)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2018)

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells
por: Giacomelli, Elisa, et al.
Publicado: (2017)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020)

Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes
por: Chen, Zhifen, et al.
Publicado: (2017)

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016)

Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2
por: Sawyer, Briana L., et al.
Publicado: (2020)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome
por: Aizawa, Takanori, et al.
Publicado: (2023)

Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease
por: van Meer, Berend J., et al.
Publicado: (2016)

Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation
por: Mihic, Anton, et al.
Publicado: (2011)

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene
por: Giustetto, Carla, et al.
Publicado: (2015)

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017)

An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort
por: Kerr, Shona M., et al.
Publicado: (2019)

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report
por: Caiffa, Thomas, et al.
Publicado: (2022)

Heart and kidney organoids maintain organ-specific function in a microfluidic system
por: Gabbin, Beatrice, et al.
Publicado: (2023)

DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells
por: Roost, Matthias S., et al.
Publicado: (2017)

Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol
por: Zhang, Shugang, et al.
Publicado: (2022)

Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing
por: Fazelifar, Amir Farjam, et al.
Publicado: (2023)

KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences
por: Ke, ZunPing, et al.
Publicado: (2023)

Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes
por: Dambrot, Cheryl, et al.
Publicado: (2014)

Novel KCNH1 Mutations Associated with Epilepsy: Broadening the Phenotypic Spectrum of KCNH1-Associated Diseases
por: von Wrede, Randi, et al.
Publicado: (2021)

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2
por: Christiansen, Michael, et al.
Publicado: (2014)

A Novel KCNH2 S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
por: Cheng, Yu-Wen, et al.
Publicado: (2023)

Inherited heart disease – what can we expect from the second decade of human iPS cell research?
por: Bellin, Milena, et al.
Publicado: (2016)

Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes
por: Tertoolen, L.G.J., et al.
Publicado: (2018)

Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells
por: Guadix, Juan Antonio, et al.
Publicado: (2017)

Long QT syndrome in chromosome 7q35q36.3 deletion involving KCNH2 gene: Warning for chlorpheniramine prescription
por: Di Stolfo, Giuseppe, et al.
Publicado: (2019)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early‐onset long QT syndrome and sinoatrial node dysfunction
por: Yang, Zhe, et al.
Publicado: (2021)

KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort
por: Lorca, Rebeca, et al.
Publicado: (2022)

Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes
por: Kekenes-Huskey, Peter M., et al.
Publicado: (2022)

Parallel derivation of isogenic human primed and naive induced pluripotent stem cells
por: Kilens, Stéphanie, et al.
Publicado: (2018)

Modeling sex differences in humans using isogenic induced pluripotent stem cells
por: Waldhorn, Ithai, et al.
Publicado: (2022)

Metabolic–Epigenetic Axis in Pluripotent State Transitions
por: D’Aniello, Cristina, et al.
Publicado: (2019)

Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia
por: Campostrini, Giulia, et al.
Publicado: (2022)

Application of Multigene Panel Sequencing in Patients with Prolonged Rate-corrected QT Interval and No Pathogenic Variants Detected in KCNQ1, KCNH2, and SCN5A
por: Seo, Soo Hyun, et al.
Publicado: (2018)

Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model
por: Ananiev, Gene, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_spqicg7bjk6rv4rrndqqav22pa